Anchanling reduces pathology in a lactacystin- induced Parkinson's disease model

Neural Regen Res. 2012 Jan 25;7(3):165-70. doi: 10.3969/j.issn.1673-5374.2012.03.001.

Abstract

A rat model of Parkinson's disease was induced by injecting lactacystin stereotaxically into the left mesencephalic ventral tegmental area and substantia nigra pars compacta. After rats were intragastrically perfused with Anchanling, a Chinese medicine, mainly composed of magnolol, for 5 weeks, when compared with Parkinson's disease model rats, tyrosine hydroxylase expression was increased, α-synuclein and ubiquitin expression was decreased, substantia nigra cell apoptosis was reduced, and apomorphine-induced rotational behavior was improved. Results suggested that Anchanling can ameliorate Parkinson's disease pathology possibly by enhancing degradation activity of the ubiquitin-proteasome system.

Keywords: Anchanling; Parkinson's disease; cell apoptosis; tyrosine hydroxylase; ubiquitin-proteasome system; α-synuclein.